Agile therapeutics reports fourth quarter & full year 2021 financial results and provides corporate update

Twirla demand grows with cycles dispensed and total prescriptions (trx) up 35% and 33% respectively in fourth quarter 2021 vs third quarter 2021

AGRX Ratings Summary

AGRX Quant Ranking